# Ethermed AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ethermed-ai

- Industry: Software
- Headquarters: Philadelphia, US
- Website: www.ethermed.ai
- Total disclosed funding: $8.5M
- Latest round: Series A (Apr 16, 2026)
- Investors on record: 4

## About

Ethermed AI Inc., based in Philadelphia, US, specializes in AI-powered solutions that optimize healthcare workflows, particularly through automating the prior authorization process for providers and payers in the healthcare industry.Ethermed AI Inc. was founded in 2021 and operates out of Philadelphia, US. The company focuses on AI-driven solutions for the healthcare sector, specifically automating prior authorization processes. In April 2026, Ethermed raised USD 8.5 mn in a Series A funding round led by Enfield Capital Partners and Blue Marlin Partners, with involvement from Jumpstart Ventures and other investors. This funding marks the company's total capital raised at USD 8.5 mn.Ethermed specializes in AI-powered prior authorization solutions designed to enhance healthcare workflows by automating the prior authorization process. The core product, EthermedAI, integrates seamlessly into existing healthcare systems, enabling healthcare providers to minimize manual processes, reduce delays, and improve operational efficiency. It functions by intercepting physician orders from electronic medical records (EMRs), analyzing authorization requirements, gathering necessary documentation, and submitting authorization requests while creating a comprehensive audit trail. EthermedAI primarily serves payers and providers across the U.S. healthcare market, addressing challenges such as reducing administrative burdens, enhancing compliance, and ensuring timely patient access to necessary treatments.Ethermed’s revenue model is primarily structured around B2B transactions, where healthcare providers and payers engage with the company to implement its AI-driven prior authorization solution. The firm operates on a subscription-based model, allowing clients continuous access to EthermedAI's functionalities. Clients benefit from significant reductions in turnaround times and denials, leading to improved financial outcomes. While specific pricing details are not disclosed, the focus remains on enhancing workflow accuracy and reducing operational costs for healthcare entities, positioning EthermedAI to generate revenue through ongoing contractual relationships.In April 2026, Ethermed AI Inc. raised USD 8.5 mn in Series A funding, co-led by Enfield Capital Partners and Blue Marlin Partners. The company plans to utilize this funding to expand its enterprise platform, enhance engineering capabilities, and scale partnerships with health systems to reduce administrative burdens and accelerate access to care. Specifically, Ethermed aims to broaden its market presence by targeting additional healthcare providers and payers across the U.S. as well as exploring opportunities for expansion into new geographic regions.

## Funding rounds

- Series A, Apr 16, 2026, $8.5M — Jumpstart Ventures, Blue Marlin Partners, Gaingels, Enfield Capital Partners

## Investors

- Jumpstart Ventures (https://capitalatlas.ai/funds/jumpstart-ventures) — Series A
- Blue Marlin Partners (https://capitalatlas.ai/funds/blue-marlin-partners) — Series A
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series A
- Enfield Capital Partners — Series A